| Entry |
|
|---|
| Name |
Pyrovalerone hydrochloride (USAN) |
|---|
| Formula |
C16H23NO. HCl
|
|---|
| Exact mass |
281.1546
|
|---|
| Mol weight |
281.82
|
|---|
| Structure |
|
|---|
| Class |
Neuropsychiatric agent
DG03059 Noradrenalin and dopamine reuptake inhibitor (NDRI)
|
|---|
| Efficacy |
Stimulant (central), Noradrenaline and dopamine reuptake inhibitor |
|---|
| Target |
|
|---|
| Pathway |
|
|---|
| Brite |
Drug groups [BR:br08330]
Neuropsychiatric agent
DG03059 Noradrenalin and dopamine reuptake inhibitor (NDRI)
D05663 Pyrovalerone hydrochloride
Target-based classification of drugs [BR:br08310]
Transporters
Solute carrier family
SLC6
SLC6A2 (NAT1)
D05663 Pyrovalerone hydrochloride (USAN)
SLC6A3 (DAT1)
D05663 Pyrovalerone hydrochloride (USAN)
Narcotics and psychotropics in Japan [br08308.html]
Psychotropics by Cabinet order Article 3 (78 substances)
D05663
|
|---|
| Other DBs |
|
|---|
| LinkDB |
|
|---|
| KCF data |
ATOM 19
1 C8x C 13.7200 -18.7600
2 C8y C 13.7200 -20.1600
3 C8x C 14.9324 -20.8600
4 C8x C 16.1449 -20.1600
5 C8y C 16.1449 -18.7600
6 C8x C 14.9324 -18.0600
7 C1a C 12.5076 -20.8600
8 C5a C 17.3760 -18.0490
9 C1c C 18.5812 -18.7447
10 O5a O 17.3757 -16.6601
11 C1b C 19.7635 -18.0619
12 N1y N 18.5816 -20.1596
13 C1b C 20.9575 -18.7512
14 C1a C 22.1454 -18.0652
15 C1x C 17.4287 -20.9983
16 C1x C 17.8700 -22.3539
17 C1x C 19.2957 -22.3531
18 C1x C 19.7355 -20.9970
19 X Cl 23.5900 -21.2100
BOND 19
1 1 2 2
2 2 3 1
3 3 4 2
4 4 5 1
5 5 6 2
6 1 6 1
7 2 7 1
8 5 8 1
9 8 9 1
10 8 10 2
11 9 11 1
12 9 12 1
13 11 13 1
14 13 14 1
15 12 15 1
16 15 16 1
17 16 17 1
18 17 18 1
19 12 18 1
|
|---|
